Dr. Russell Szmulewitz, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Prostate Cancer
Russell Szmulewitz, MD has run 17 trials for Prostate Cancer. Some of their research focus areas include:
Prostate Adenocarcinoma
Russell Szmulewitz, MD has run 3 trials for Prostate Adenocarcinoma.
Affiliated Hospitals
University Of Chicago
University Of Chicago Comprehensive Cancer Center
Clinical Trials Russell Szmulewitz, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting
2 awards
Phase 3
More about Russell Szmulewitz, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Russell Szmulewitz, MD has experience with
- Enzalutamide
- Prednisone
- Darolutamide
- Relacorilant
- Abiraterone Acetate
- Apalutamide
Breakdown of trials Russell Szmulewitz, MD has run
Prostate Cancer
Prostate Adenocarcinoma
Abnormal DNA Repair
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Russell Szmulewitz, MD specialize in?
Russell Szmulewitz, MD focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PSA positive.
Is Russell Szmulewitz, MD currently recruiting for clinical trials?
Yes, Russell Szmulewitz, MD is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Russell Szmulewitz, MD has studied deeply?
Yes, Russell Szmulewitz, MD has studied treatments such as Enzalutamide, Prednisone, Darolutamide.
What is the best way to schedule an appointment with Russell Szmulewitz, MD?
Apply for one of the trials that Russell Szmulewitz, MD is conducting.
What is the office address of Russell Szmulewitz, MD?
The office of Russell Szmulewitz, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60453 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.